INSP Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (21 mai 2024 @ 22:00):

Stats
Dagens volum	683 289
Gjennomsnittsvolum	581 877
Markedsverdi	4.53B
EPS	$0 ( 2024-05-07 )
Neste inntjeningsdato	( $0 ) 2024-07-30
Last Dividend	$9.00 ( 2008-01-09 )
Next Dividend	$0 ( N/A )
P/E	-287.49
ATR14	$0.184 (0.12%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-10	Mccormick Shawn	Buy	2 500	Common Stock
2024-05-10	Mccormick Shawn	Sell	2 500	Stock Option (Right to Buy)
2024-05-02	Burks Cynthia	Buy	716	Common Stock
2024-05-02	Tansey Casey M	Buy	716	Common Stock
2024-05-02	Ellis Gary Lee	Buy	716	Common Stock

INSIDER POWER
5.08
Last 100 transactions
Buy: 146 836 \| Sell: 127 702

Volum Korrelasjon

Lang: -0.34 (neutral)

Kort: 0.29 (neutral)

Signal:(55.319) Neutral

Inspire Medical Systems Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Inspire Medical Systems Korrelasjon - Valuta/Råvare

-0.24
( neutral )

-0.08
( neutral )

0.00
( neutral )

-0.16
( neutral )

-0.59
( weak negative )

-0.69
( moderate negative )

Inspire Medical Systems Økonomi

Annual	2023
Omsetning:	$624.80M
Bruttogevinst:	$528.22M (84.54 %)
EPS:	$-0.720

FY	2023
Omsetning:	$624.80M
Bruttogevinst:	$528.22M (84.54 %)
EPS:	$-0.720

FY	2022
Omsetning:	$407.86M
Bruttogevinst:	$341.74M (83.79 %)
EPS:	$-1.600

FY	2021
Omsetning:	$233.39M
Bruttogevinst:	$200.12M (85.74 %)
EPS:	$-1.540

Financial Reports:

No articles found.

Inspire Medical Systems Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Inspire Medical Systems Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 7.27 - good (72.66%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Information

First Dividend	$9.00	2008-01-09
Last Dividend	$9.00	2008-01-09
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	$9.00	--
Avg. Dividend % Per Year	0.00%	--
Score	1.05	--
Div. Sustainability Score	7.27
Div.Growth Potential Score	0
Div. Directional Score	3.46	--

Next Divdend (Est)
(2024-05-21)

$0 Estimate 0.00 %

Dividend Stability

0.00 Very Bad

Dividend Score

1.05

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield
2008	$0	0.00%
2009	$0	0.00%
2010	$0	0.00%
2011	$0	0.00%
2012	$0	0.00%
2013	$0	0.00%
2014	$0	0.00%
2015	$0	0.00%
2016	$0	0.00%
2017	$0	0.00%
2018	$0	0.00%
2019	$0	0.00%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend King	2023-06-30	Quarterly	2	5.23%	8.53
PDI	Dividend Royal	2023-11-10	Monthly	13	7.86%	8.50
ORC	Dividend Royal	2023-11-29	Monthly	12	9.23%	8.50
NCV	Dividend Royal	2024-02-09	Monthly	22	7.68%	8.50
JQC	Dividend Royal	2023-11-14	Monthly	22	6.56%	8.50
MTR	Dividend Royal	2023-10-30	Monthly	39	10.10%	8.50
ZTR	Dividend King	2024-02-09	Monthly	37	8.35%	8.50
PHK	Dividend Royal	2023-11-10	Monthly	22	6.88%	8.50
SBR	Dividend Royal	2023-11-14	Monthly	38	7.74%	8.50
SCM	Dividend Royal	2023-12-15	Monthly	13	7.08%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.0238	1.500	-0.476	-0.714	[0 - 0.5]
returnOnAssetsTTM	-0.0229	1.200	-0.765	-0.918	[0 - 0.3]
returnOnEquityTTM	-0.0282	1.500	-1.424	-2.14	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	7.93	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	7.12	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	2.43	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.0357	-1.500	9.40	-10.00	[0 - 0.6]
interestCoverageTTM	-8.39	1.000	-4.22	-4.22	[3 - 30]
operatingCashFlowPerShareTTM	1.177	2.00	9.61	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.111	2.00	9.94	10.00	[0 - 20]
debtEquityRatioTTM	0.0416	-1.500	9.83	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.847	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	-0.0545	1.000	-3.09	-3.09	[0.1 - 0.6]
cashFlowToDebtRatioTTM	1.423	1.000	3.21	3.21	[0.2 - 2]
assetTurnoverTTM	0.964	0.800	6.91	5.53	[0.5 - 2]
Total Score				7.27

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-292.29	1.000	-10.00	0	[1 - 100]
returnOnEquityTTM	-0.0282	2.50	-0.915	-2.14	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.111	2.00	9.96	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	1.177	2.00	9.61	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-22.92	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0527	1.000	-1.181	0	[0.1 - 0.5]
Total Score				-0.347

Inspire Medical Systems Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Inspire Medical Systems

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.